PTC Therapeutics

From Wikipedia, the free encyclopedia

Jump to: navigation, search

PTC Therapeutics is a pharmaceutical company. It is headquartered in South Plainfield, New Jersey.

They are the company responsible for the development of PTC124.[1]

[edit] References

  1. ^ Hamed SA (2006). "Drug evaluation: PTC-124--a potential treatment of cystic fibrosis and Duchenne muscular dystrophy". IDrugs : the investigational drugs journal 9 (11): 783–9. PMID 17096300.

[edit] External links

Views
Personal tools

Toolbox